The effect of Myoinositol on the outcomes of assisted reproductive treatments in patients with polycystic ovary syndrome
Phase 3
- Conditions
- Female infertility associated with anovulation.Female infertility associated with anovulationN97.0
- Registration Number
- IRCT20240119060732N2
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 98
Inclusion Criteria
Women with polycystic ovary syndrome according to ESHRE-ASRM criteria
Infertile women
Exclusion Criteria
Body mass index above 35
Endometriosis
Azospermia
Sever oligospermia
Hydrosalpinx
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The oocyte quality. Timepoint: Once, at the puncture day. Method of measurement: The embryologist reports.;The oocyte number. Timepoint: Once, at the puncture day. Method of measurement: The embryologist reports.;The embryo quality. Timepoint: Once, at the puncture day. Method of measurement: The embryologist reports.
- Secondary Outcome Measures
Name Time Method Clinical pregnancy. Timepoint: Once, six weeks after fetal transfer. Method of measurement: Ultrasound.